Kelly C. Wade, M.D., Ph.D., M.S.C.E.
Professor of Clinical Pediatrics (Neonatology & Newborn Services)
Attending Neonatologist, Department of Pediatrics, Children's Hospital of Philadelphia
Attending Neonatologist, CHOP Newborn Care at Pennsylvania Hospital
Associate Director, Therapeutics, CHOP Newborn Care at Pennsylvania Hospital
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia Newborn Care
Pennsylvania Hospital
800 Spruce Street
Philadelphia, PA 19107
Pennsylvania Hospital
800 Spruce Street
Philadelphia, PA 19107
Office: 215-829-3301
Fax: 215-829-7211
Fax: 215-829-7211
Education:
B.S. (Biochemistry)
University of California, Davis, 1989.
M.S. (Genetics)
Yale School of Medicine, 1993.
Ph.D. (Genetics)
Yale School of Medicine, 1996.
M.D. (Medicine)
Yale School of Medicine, 1997.
M.S.C.E. (Clinical Epidemiology and Biostatistics)
University of Pennsylvania, 2010.
Permanent linkB.S. (Biochemistry)
University of California, Davis, 1989.
M.S. (Genetics)
Yale School of Medicine, 1993.
Ph.D. (Genetics)
Yale School of Medicine, 1996.
M.D. (Medicine)
Yale School of Medicine, 1997.
M.S.C.E. (Clinical Epidemiology and Biostatistics)
University of Pennsylvania, 2010.
Description of Research Expertise
Neonatal Pharmacology, population PK, and neonatal drug dosingDescription of Clinical Expertise
Medication Safety in the Neonatal ICUSelected Publications
Coggins SA, Wade KC, Watt KM, Downes KJ, Puopolo KM.: Vancomycin Concentrations in Umbilical Cord Blood After Intrapartum Exposure. Obstet Gynecol 145: 435-438, Apr 2025.Coggins SA, Wade KC, Watt KM, Downes KJ, Puopolo KM: Umbilical cord blood gentamicin concentrations following maternally-administered intrapartum exposures. Pediatr Res Oct 2024 Notes: Peer reviewed correspondence.
Wade KC, Greenberg RG, Benjamin DK Jr, Chen LL, Vo B, Ang BL, Boutzoukas A, Zimmerman K, Clark RH, Cohen-Wolkowiez M, Le J; Administrative Core Committee of the Best Pharmaceuticals for Children Act – Pediatric Trials Network.: Postdiscontinuation Antibiotic Exposure in Hospitalized Infants at Risk for Late-onset Sepsis in the Neonatal Intensive Care Unit. Pediatr Infect Dis J 43(10): 991-996, Oct 2024.
Flannery DD, Zevallos Barboza A, Mukhopadhyay S, Gerber JS, McDonough M, Shu D, Hennessy S, Wade KC, Puopolo KM.: Antibiotic use among extremely low birth-weight infants from 2009 to 2021: a retrospective observational study. Arch Dis Child Fetal Neonatal Ed 110: doi: 10.1136/archdischild-2023-326734. Sep 2024 Notes: epub ahead of print.
Flannery DD, Zevallos Barboza A, Mukhopadhyay S, Wade KC, Gerber JS, Shu D, Puopolo KM.: Antibiotic Use Among Infants Admitted to Neonatal Intensive Care Units. JAMA Pediatr 177: 1354-1356, Dec 2023.
Flannery DD, Zevallos Barboza A, Wade KC, Pfeifer MR, Gerber JS, Morris JS, Puopolo KM.: Measles Serostatus Among Parturient Patients at 2 Philadelphia Hospitals in 2021. JAMA 329: 682-684, Feb 2023.
Mukhopadhyay S, Lee JJ, Hartman E, Woodford E, Dhudasia MB, Mattei LM, Daniel SG, Wade KC, Underwood MA, Bittinger K.: Preterm infants at low risk for early-onset sepsis differ in early fecal microbiome assembly. Gut Microbes 14: e2154091, Dec 2022.
Mukhopadhyay S, Itell HL, Hartman E, Woodford E, Dhudasia MB, Steppe JT, Valencia S, Roark H, Wade KC, Weimer KED, Permar SR, Puopolo KM.: Breast Milk and Saliva for Postnatal Cytomegalovirus Screening among Very Low Birth Weight Infants. Pediatr Infect Dis J 41: 904-910, Nov 2022.
Le J, Greenberg RG, Yoo Y, Clark RH, Benjamin DK Jr, Zimmerman KO, Cohen-Wolkowiez M, Wade KC; Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee.: Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardship. J Perinatol 42(7): 959-964, July 2022.
Lewis T, Terrin N, Davis J, Michels K, Salaets T, Wade K; International Neonatal Consortium.: Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data. J Perinatol 41: 2813, Dec 2021.